Description
METAGLYN 2
Metformin Hydrochloride 500 mg + Glimepiride 2 mg Tablets
METAGLYN 2 – Dual Action for Effective Blood Sugar Management
METAGLYN 2 is a combination of Metformin Hydrochloride 500 mg and Glimepiride 2 mg, designed to provide effective glycemic control in patients with Type 2 Diabetes Mellitus. The dual-action formulation helps improve insulin sensitivity while stimulating insulin secretion, resulting in better blood glucose control and reduced risk of diabetes-related complications.
Marketed under Coresure, the dedicated Cardiac & Diabetic Division of ZivHealth, METAGLYN 2 is manufactured under stringent quality standards to deliver consistent efficacy, safety, and patient confidence.
Composition
Each Film-Coated Tablet Contains:
- Metformin Hydrochloride IP 500 mg
- Glimepiride IP 2 mg
Dosage: As directed by the physician.
Key Benefits
- Provides effective control of fasting and postprandial blood glucose
- Improves insulin sensitivity and glucose utilization
- Stimulates pancreatic insulin secretion
- Helps achieve long-term glycemic control
- Reduces the risk of diabetes-related complications
- Convenient dual-drug therapy for improved patient compliance
Indications
METAGLYN 2 is indicated for:
- Type 2 Diabetes Mellitus
- Inadequate glycemic control with diet and exercise alone
- Patients requiring combination oral antidiabetic therapy
- Long-term diabetes management under physician supervision
Mechanism of Action
Metformin Hydrochloride reduces hepatic glucose production, decreases intestinal glucose absorption, and improves insulin sensitivity, enabling better glucose utilization.
Glimepiride is a sulfonylurea that stimulates insulin release from pancreatic beta cells, helping lower blood glucose levels effectively.
The combination provides complementary mechanisms for superior glycemic control in Type 2 Diabetes Mellitus.
Why Choose METAGLYN 2?
- WHO-GMP quality manufacturing
- Clinically trusted antidiabetic combination
- Consistent therapeutic efficacy
- Premium-quality packaging
- Competitive pricing
- Reliable product availability
About Coresure – Cardiac & Diabetic Division of ZivHealth
Coresure is the specialized Cardiac & Diabetic Division of ZivHealth, focused on delivering high-quality medicines for diabetes and cardiovascular care. Our portfolio is developed to support physicians in managing chronic lifestyle disorders with formulations manufactured under stringent quality standards.
Our growing range includes:
- Oral Antidiabetic Medicines
- Cardiovascular Medicines
- Antihypertensives
- Lipid-Lowering Agents
- Antiplatelets
- Nutraceuticals for Cardio-Metabolic Health
With quality manufacturing, reliable supply, attractive packaging, and dedicated franchise support, Coresure is committed to improving patient care while helping pharma partners build a successful chronic therapy business.
Product Highlights
- Metformin 500 mg + Glimepiride 2 mg
- WHO-GMP manufactured
- Effective dual-action antidiabetic therapy
- Premium packaging
- Reliable nationwide availability
- Ideal for chronic diabetes management


Reviews
There are no reviews yet.